Tuesday, April 29, 2025

RWS Expands Global Offering with RWS Life Sciences

The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS' market leadership and continued growth of life science language servicesOn October 1, 2017 RWS, the world's leading provider of translation, intellectual property, life sciences...

ADM Tronics Prepares New Respiratory Therapy Device for Market

ADM Tronics Unlimited, Inc. (OTCQB - ADMT) is in the final stage of developing the Alvio™ device, a new technology it has had under development pursuant to its previously announced agreement with QOL...

Boston Scientific Announces Agreement to Acquire Apama Medical

Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments for Patients with Atrial FibrillationBoston Scientific Corporation today announced a definitive agreement to acquire Apama Medical Inc., a...

Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

Novel Compound with Potential for Early Detection and to Guide Treatment of Colorectal CancerEdinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it has commenced a...

New Models and Approaches to Condition Management Leading to Accelerated Growth of Solutions

New Chilmark Research report assesses maturity of solution features, sets forth rationale for rapid growth.Key healthcare stakeholders are accelerating the adoption of more personalized and holistic approaches to chronic condition management, driven by...

Alzheimer’s Disease: Cannabis Formulation Shows Promise

Known as America's most expensive disease, with an estimated cost to the U.S. economy of 6 billion in 2016, Alzheimer's disease (AD) affects more than 5.3 million Americans.Over the next 20 years, the number of...

FDA approves Mylotarg for treatment of acute myeloid leukemia

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also...

Sutter Health Collaborates with Qventus to Drive Down Pharmaceutical Costs

The not-for-profit Sutter Health network announced today that it will collaborate with Qventus to use the company's artificial intelligence (AI) platform to enhance inpatient pharmacy operations across its healthcare system.The real-time platform...

Connect with us

4,406FansLike
1,007FollowersFollow
3,498FollowersFollow

Popular Posts